Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ashwin Koppayi

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Biorxiv : the Preprint Server for Biology|June 4, 2026
A Novel Network Approach to Identify Sample-Specific Context-Informed Metabolic Signatures During Developmental ProcessesEmma Lee, Ashwin Koppayi, Almudena Veiga-Lopez, et al.
Blood Neoplasia|February 13, 2026
FLT3 as a germ line driver in AML: expanding the landscape of leukemia predispositionAlok Swaroop, Natasha L Johnson, Michelle C Tophkhane, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 6, 2023
Sequential tumor molecular profiling identifies likely germline variantsIra L Kraft, Hatice Basdag, Ashwin Koppayi, et al.
Leukemia|May 7, 2025
Predisposition to hematopoietic malignancies by deleterious germline CHEK2 variantsRyan J Stubbins, Stephen Arnovitz, Jennie Vagher, et al.
Haematologica|February 13, 2025
Overall cancer risk in people with deleterious germline <i>DDX41</i> variantsSophia C Korotev, Jason X Cheng, Yogameenakshi Haribabu, et al.
Blood|July 11, 2024
Germ line ERG haploinsufficiency defines a new syndrome with cytopenia and hematological malignancy predispositionJiarna R Zerella, Claire C Homan, Peer Arts, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Biorxiv : the Preprint Server for Biology|June 4, 2026
A Novel Network Approach to Identify Sample-Specific Context-Informed Metabolic Signatures During Developmental ProcessesEmma Lee, Ashwin Koppayi, Almudena Veiga-Lopez, et al.
Blood Neoplasia|February 13, 2026
FLT3 as a germ line driver in AML: expanding the landscape of leukemia predispositionAlok Swaroop, Natasha L Johnson, Michelle C Tophkhane, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 6, 2023
Sequential tumor molecular profiling identifies likely germline variantsIra L Kraft, Hatice Basdag, Ashwin Koppayi, et al.
Leukemia|May 7, 2025
Predisposition to hematopoietic malignancies by deleterious germline CHEK2 variantsRyan J Stubbins, Stephen Arnovitz, Jennie Vagher, et al.
Haematologica|February 13, 2025
Overall cancer risk in people with deleterious germline <i>DDX41</i> variantsSophia C Korotev, Jason X Cheng, Yogameenakshi Haribabu, et al.
Blood|July 11, 2024
Germ line ERG haploinsufficiency defines a new syndrome with cytopenia and hematological malignancy predispositionJiarna R Zerella, Claire C Homan, Peer Arts, et al.
Pageof 1